» Authors » Cassandra Johnson

Cassandra Johnson

Explore the profile of Cassandra Johnson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 431
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Geiger S, Khaium M, Gustafson E, Shapiro M, Keeley S, Johnson C, et al.
Front Public Health . 2025 Mar; 13:1521545. PMID: 40078769
Introduction: This ecologic study explores the relationship between the Social Vulnerability Index (SVI) and probable asthma-related emergency medical service (EMS) rates before and during the COVID-19 pandemic at the county...
2.
Silva V, Johnson C, Fronek L, Miller R
J Drugs Dermatol . 2025 Mar; 24(3):289-293. PMID: 40043267
One of the most common complications in dermatologic surgery is postoperative bleeding which can result in hematoma formation and suboptimal healing outcomes. Identifying preoperative, intraoperative, and postoperative risk factors can...
3.
Link-Gelles R, Chickery S, Webber A, Ong T, Rowley E, DeSilva M, et al.
MMWR Morb Mortal Wkly Rep . 2025 Feb; 74(6):73-82. PMID: 40014628
COVID-19 vaccination averted approximately 68,000 hospitalizations during the 2023-24 respiratory season. In June 2024, CDC and the Advisory Committee on Immunization Practices (ACIP) recommended that all persons aged ≥6 months...
4.
DeCuir J, Surie D, Zhu Y, Lauring A, Gaglani M, McNeal T, et al.
Influenza Other Respir Viruses . 2024 Nov; 18(11):e70027. PMID: 39496339
Background: Assessments of COVID-19 vaccine effectiveness are needed to monitor the protection provided by updated vaccines against severe COVID-19. We evaluated the effectiveness of original monovalent and bivalent (ancestral strain...
5.
Bhullar P, Motaparthi K, Zieman D, Johnson C, Gurnani P, Sokumbi O
J Cutan Pathol . 2024 Jul; 51(10):767-772. PMID: 38982730
Chimeric antigen receptor (CAR) T-cell therapy has demonstrated remarkable success in treating various B-cell malignancies, redirecting T-cell cytotoxicity toward cancer cells. Despite its efficacy, CAR-T therapy is associated with potential...
6.
DeCuir J, Payne A, Self W, Rowley E, Dascomb K, DeSilva M, et al.
MMWR Morb Mortal Wkly Rep . 2024 Feb; 73(8):180-188. PMID: 38421945
In September 2023, CDC's Advisory Committee on Immunization Practices recommended updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination for all persons aged ≥6 months to prevent COVID-19, including severe disease. However, few...
7.
Raglow Z, Surie D, Chappell J, Zhu Y, Martin E, Kwon J, et al.
Lancet Microbe . 2024 Jan; 5(3):e235-e246. PMID: 38286131
Background: Prolonged SARS-CoV-2 infections in people who are immunocompromised might predict or source the emergence of highly mutated variants. The types of immunosuppression placing patients at highest risk for prolonged...
8.
Lewis N, Zhu Y, Peltan I, Gaglani M, McNeal T, Ghamande S, et al.
Clin Infect Dis . 2023 Dec; 78(4):1056-1064. PMID: 38051664
Background: Influenza circulation during the 2022-2023 season in the United States largely returned to pre-coronavirus disease 2019 (COVID-19)-pandemic patterns and levels. Influenza A(H3N2) viruses were detected most frequently this season,...
9.
Raglow Z, Surie D, Chappell J, Zhu Y, Martin E, Kwon J, et al.
medRxiv . 2023 Sep; PMID: 37662226
Background: Prolonged SARS-CoV-2 infections in immunocompromised hosts may predict or source the emergence of highly mutated variants. The types of immunosuppression placing patients at highest risk for prolonged infection and...
10.
Johnson C, Parsa L, Gibbs J, Sligh J
J Cutan Pathol . 2023 May; 51(1):11-14. PMID: 37150806
Superficial CD34 fibroblastic tumors (SCD34FT) and PRDM10-rearranged tumors (PRTs) are mesenchymal tumors that have recently received increased scientific attention due to their irrefutable similarities yet debatable relationship. A 74-year-old male...